✦ LIBER ✦

AUTOIMMUNE URTICARIA RESPONSE TO HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN

✍ Scribed by Klote, Mary M.; Nelson, Michael R.; Engler, Renata J.M.

Book ID: 123350567
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 116 KB
Volume: 94
Category: Article
ISSN: 1081-1206
DOI: 10.1016/S1081-1206(10)61313-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous immunoglobulin in autoimmune

Intravenous immunoglobulin in autoimmune chronic urticaria

✍ O'donnell; Barr; Kobza Black; Francis; Kermani; Niimi; Barlow; Winkelmann; Greav 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

Histamine releasing autoantibodies play a central role in the pathogenesis of chronic urticaria (CU) in approximately 30% of affected patients. We investigated the therapeutic effect of high-dose intravenous immunoglobulin (IVIG) on disease activity in patients with severe CU of autoimmune aetiology

Scleromyxedema: Response to high-dose in

Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)

✍ Robert K. Lister; Stephen Jolles; Sean Whittaker; Carol Black; Ian Forgacs; Matt 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Nephrogenic fibrosing dermopathy: respon

Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin

✍ H-J. Chung; K-Y. Chung 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Immunomodulation of autoimmune diseases

Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins

✍ Rauova, Lubica ;Rovensky, Jozef ;Shoenfeld, Yehuda 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 746 KB

Safety of high-dose intravenous immunogl

Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases

✍ Fatih Tufan; Sevil Kamali; Burak Erer; Ahmet Gul; Murat Inanc; Lale Ocal; Meral 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 73 KB

Psoriasis: response to high-dose intrave

Psoriasis: response to high-dose intravenous immunoglobulin in three patients

✍ V. Gurmin; R. Mediwake; M. Fernando; S. Whittaker; M.H.A. Rustin; H.L.C. Beynon 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Treatment of recalcitrant psoriasis and psoriatic arthritis can be challenging, with treatment options limited by drug intolerance or poor efficacy. High-dose intravenous immunoglobulin (hdIVIg) has been used successfully in Kawasaki's disease and idiopathic thrombocytopenic purpura, where it has be